Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

France Nouvelles Nouvelles

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222
France Dernières Nouvelles,France Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 65 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 71%

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222 medrxivpreprint BrighamWomens MeridianClinRes immunogenicity Omicron mRNA COVID19 coronavirus covid SARSCoV2

By Dr. Chinta SidharthanDec 19 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, a team of researchers evaluated the immunogenicity and safety of the coronavirus disease 2019 bivalent messenger ribonucleic acid vaccine mRNA-1273.222 and tested the neutralizing ability of the two bivalent vaccines — mRNA-1273.222 and mRNA-1273.214 — against the newly emergent Omicron subvariants.

Clinical trials have shown that the mRNA-1273.214 bivalent vaccine containing Omicron BA.1 does not cause adverse reactions and elicits a stronger neutralizing antibody response against Omicron BA.1. The vaccine was also seen to be cross-reactive against Omicron subvariants BA.2.75 and BA.4/BA.5. The mRNA-1273 vaccine comprises a single mRNA that codes for the spike glycoprotein of the SARS-CoV-2 Wuhan-Hu-1 strain, while the bivalent vaccine contains an additional mRNA encoding the Omicron BA.4/BA.5 spike glycoprotein.

The immunogenicity assessment objectives included calculating the seroresponse rate difference and geometric mean titer ratio to determine non-inferior neutralizing antibody responses against the D614G mutation carrying ancestral SARS-CoV-2 strain and the Omicron BA.4/BA.5 subvariant, and the superior neutralizing antibody responses against Omicron BA.4/BA.5 based on GMR values four weeks after the administration of the monovalent or bivalent booster vaccine.

The GMT values for neutralizing antibody responses against Omicron BA.4/BA.5 after the administration of the mRNA-1273.222 and mRNA-1273 booster dose were 2324.6 and 488.5, respectively, while those against the ancestral D614G strain were 7322.6 and 5651.4, respectively.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Terrified diners rush to safety after fire breaks out at posh London restaurantTerrified diners rush to safety after fire breaks out at posh London restaurantTerrified diners were forced to run for their lives after a fire tore through a posh restaurant in London, with footage posted on social media showing guests scrambling to escape.
Lire la suite »

Concert goer helps '200 people' to safety in fire exit escape during Asake 'crowd crush'Concert goer helps '200 people' to safety in fire exit escape during Asake 'crowd crush'Kamaru Ogunkoya says he found a fire exit amid the tragedy that helped him and hundreds of others escape
Lire la suite »

Homes flooded after massive water main burst turns street into 'a river'Homes flooded after massive water main burst turns street into 'a river'People have been evacuated from their homes in a flooded Camden street after a water main burst in the early hours of this morning.
Lire la suite »

'No easy options' for closed ford as new bridge deemed too costly'No easy options' for closed ford as new bridge deemed too costlyIt was recently closed for the foreseeable future amid safety concerns from Nottinghamshire Police. A longer-term solution is now being developed.
Lire la suite »



Render Time: 2025-03-07 02:05:30